Type 2 Diabetes (Practitioners) USA - geneType™
menu

Personalized risk assessment

geneType™ for Type 2 Diabetes provides personalized risk assessment integrating clinical, familial and genetic risk factors.

geneType™ for Type 2 Diabetes is appropriate for:

  • Men and women
  • Ages 40 – 85 years
  • Fasting blood glucose < 126mg/dL

Testing is simple

Step 1

Register as a provider; our team will provide clinical education and other resources as needed.

We will send kits to your clinic to have on hand.

Step 2

Discuss geneType™ with your patient.

Would geneType™ help them qualify for additional risk reduction strategies?

Step 3

Complete the Test Requisition form, collect a saliva sample from the patient with the collection kit provided and return both to Rhythm.

You will have the option to use a paper requisition, or a secure, compliant portal to complete the ordering process.

Step 4

Leave the rest to us.

We will notify you when your patient’s results are ready.

You will have the option to request a consult with a genetic counsellor, whether to review your patient’s results and/or to follow-up with your patient, as needed.

Register as a geneType™ provider

One report. Actionable insights.

Our reports are structured to make the results easy to interpret and communicate to a patient.

The geneType™ for Type 2 Diabetes report includes:

  • A snapshot of your patient’s 8-year risk score
  • Interpretation of what their risk score means in the context of current guidelines
  • Polygenic risk score indicating your patient’s “baseline” type 2 diabetes risk
  • Information about modifying type 2 diabetes risk factors
  • Types of screening and risk-reducing interventions that may be relevant to your patient’s risk category
Request more information

Do you have questions? We have answers.

If your question is not shown here, please Contact us directly.

I use a traditional type 2 diabetes risk assessment model, why should I choose geneType?

The benefit of geneType™ is in the common genetic markers that we examine and incorporate with other standard markers of risk, like cholesterol or fasting glucose levels. This give you an advantage to visualize a component of your patient’s risk that you can’t see in traditional risk models. This leads to improved stratification, particularly in adults that may present with minimal clinical risk factors, but may have a high “baseline” risk based on these common genetic markers. Importantly, lifestyle modifications are effective in reducing type 2 diabetes risk across all genetic risk categories.

Is this test reimbursed by insurance?

No. At this time geneType™ is a self-pay test. However, your patient may use FSA/HSA to pay for the test.

*Patient eligibility dependent on personal medical history, age and sex

Interested in ordering more than one disease? Order geneType™ Multi-Test.

The Multi-Risk suite of tests is for adults 40-85 years of age. At maximum, a woman would be eligible for eight diseases in the panel; a man would be eligible for seven. Starting at age 30, a patient may qualify for geneType’s™ cancer risk assessments only.

 

References
  1. Cowie CC, et al. Diabetes in America. 3rd ed. Bethesda (MD): National Institute of Diabetes and Digestive and
    Kidney Diseases (US); 2018 Aug. CHAPTER 3: Prevalence and Incidence of Type 2 Diabetes and Prediabetes
  2. Jonas DE et al.JAMA. 2021;326(8):744-760.
  3. Ali MK et al. JAMA Netw Open. 2019 May 3;2(5):e193160.
  4. Centers for Disease Control and Prevention(CDC). National Diabetes Prevention Program. Available at: https://www.cdc.gov/diabetes/images/library/socialmedia/NDPP_WorkingTogetherDiabetes_Print.pdf. accessed June 2022
  5. American Diabetes Association Professional Practice Committee. Diabetes Care. 2022;45(Suppl 1):S17–S38.

Accredited For Compliance With NPAAC Standards And ISO 15189